Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty

被引：72
|
作者：
Zorman, S
Zorman, D
Noc, M
机构：
[1] Univ Med Ctr, Ctr Intens Internal Med, Ljubljana, Slovenia
[2] Univ Med Ctr, Dept Cardiol, Ljubljana, Slovenia
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2002年 / 90卷 / 05期
关键词：
D O I：
10.1016/S0002-9149(02)02530-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Abciximab pretreatment in patients with ST-elevation myocardial infarction restored Thrombolysis In Myocardial Infarction grade 2/3 flow in 32% of patients. Despite comparable final angiographic success of primary angioplasty, complete resolution of ST-segment elevation was observed in 70% of abciximab-pretreated patients, and in only 36% and 37% of patients receiving abciximab immediately before angioplasty or no abciximab, respectively.
引用
收藏
页码：533 / +
页数：5
相关论文
共 50 条
  • [21] Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction
    Smit, Jaap Jan J.
    van't Hof, Arnoud W. J.
    de Boer, Menko Jan
    Hoorntje, Jan C. A.
    Dambrink, Jan Henk E.
    Gosselink, A. T. Marcel
    Ottervanger, Jan Paul
    Kolkman, J. J. Evelien
    Suryapranata, Harry
    THROMBOSIS AND HAEMOSTASIS, 2006, 96 (02) : 190 - 195
  • [22] Prognostic value of QRS distorsion in acute myocardial infarction patients undergoing primary angioplasty
    Colombo, P
    Corrada, E
    Mafrici, A
    Bossi, I
    Alberti, A
    Bigi, R
    Fiorentini, C
    Klugmann, S
    EUROPEAN HEART JOURNAL, 2003, 24 : 383 - 383
  • [23] Influence of mild to moderate thrombocytosis in patients undergoing primary angioplasty for acute myocardial infarction
    Sadeghi, HM
    Stuckey, T
    Dixon, SR
    Brodie, BR
    Griffin, JJ
    Carroll, JD
    CIRCULATION, 2003, 108 (17) : 357 - 358
  • [24] Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction
    Harjai, KJ
    Stone, GW
    Boura, J
    Mattos, L
    Chandra, H
    Cox, D
    Grines, L
    O'Neill, W
    Grines, C
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (09): : 1041 - 1045
  • [25] β-blocker use in the emergency department in patients with acute myocardial infarction undergoing primary angioplasty
    Pancu, D
    Lee, DC
    JOURNAL OF EMERGENCY MEDICINE, 2003, 24 (04): : 379 - 382
  • [26] Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty
    Beeres, SLMA
    Oemrawsingh, PV
    Warda, HM
    Bechan, R
    Atsma, DE
    Jukema, JW
    van der Wall, EE
    Schalij, MJ
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 65 (04) : 478 - 483
  • [27] Microcirculation recovery after primary coronary angioplasty in patients with acute myocardial infarction treated with Abciximab or intracoronary Adenosina
    Petronio, AS
    Musumeci, G
    Nardi, C
    Limbruno, U
    Amoroso, G
    Baglini, R
    Palagi, C
    Manani, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 388A - 388A
  • [28] Effects of single high-dose bolus of tirofiban or abciximab during primary angioplasty for acute myocardial infarction in patients with renal failure
    Colangelo, S.
    Boccuzzi, G.
    Garbo, R.
    Noussan, P.
    Campo, G.
    Valgimigli, M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 205 - 205
  • [29] Acute myocardial infarction: primary angioplasty
    Zijlstra, F
    HEART, 2001, 85 (06) : 705 - 709
  • [30] Renal protection with N-acetylcysteine for patients undergoing primary angioplasty for acute myocardial infarction
    Marenzi, G
    Assanelli, E
    Lauri, G
    Campodonico, J
    Marana, I
    Grazi, M
    De Metrio, M
    Bartorelli, AL
    EUROPEAN HEART JOURNAL, 2004, 25 : 515 - 515
12345